Joint Formulary & PAD

Lidocaine - Premature Ejaculation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Spray
Associated Icons :
NFD2
SPC
Restrictions / Comments :
Important

This product has not been assessed for addition to formulary. Contact pharmacy for advice.

Note - this is a P medicine which is available to purchase from a Pharmacy.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Lidocaine
Indication :
Premature Ejaculation
Group Name :
Keywords :
Brand Names Include :
STUD 100
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Drugs

Below are listed other drugs that are used to treat Premature Ejaculation.

  • No records returned.

Committee Recommendations (1)

This product has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this product.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicans can contact syheartlandsccg.APC@nhs.net
if they wish to make a submission. 

Note - this product is a "P" medicine and may be purchased from a pharmacy.